Wobig R J, Kempton J b, Trune D R
Department of Otolaryngology-Head and Neck Surgery, Oregon Hearing Research Center, Oregon Health Sciences University, Portland, 97201-3098, USA.
Otolaryngol Head Neck Surg. 1999 Oct;121(4):344-7. doi: 10.1016/S0194-5998(99)70218-4.
Corticosteroids historically have been used to treat autoimmune sensorineural hearing loss, although little is known of how steroids restore normal inner ear function. Therefore, to identify a potential model for this field of research, this study examined the effects of prednisolone on auditory brain stem response thresholds in the MRL/lpr mouse model of autoimmune sensorineural hearing loss. Mice treated with prednisolone after auditory threshold elevations demonstrated significant improvement and stabilization of thresholds compared with untreated controls. MRL/lpr mice treated with steroids before the onset of autoimmune disease and cochlear dysfunction demonstrated decreased serum immune complexes, higher survival rates, and lower auditory thresholds compared with untreated controls. These positive results suggest the autoimmune mouse may be useful for studies of steroid-responsive mechanisms of the cochlea in autoimmune sensorineural hearing loss, as well as any hearing disorder in which steroid therapy is currently used.
从历史上看,皮质类固醇一直被用于治疗自身免疫性感音神经性听力损失,尽管对于类固醇如何恢复内耳正常功能知之甚少。因此,为了确定该研究领域的潜在模型,本研究在自身免疫性感音神经性听力损失的MRL/lpr小鼠模型中检测了泼尼松龙对听觉脑干反应阈值的影响。与未治疗的对照组相比,听觉阈值升高后接受泼尼松龙治疗的小鼠阈值有显著改善和稳定。在自身免疫性疾病和耳蜗功能障碍发作前接受类固醇治疗的MRL/lpr小鼠与未治疗的对照组相比,血清免疫复合物减少、存活率更高且听觉阈值更低。这些阳性结果表明,自身免疫性小鼠可能有助于研究自身免疫性感音神经性听力损失中类固醇反应性耳蜗机制,以及目前使用类固醇治疗的任何听力障碍。